About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 962 record(s)
Req # A-2023-001369
Obtain data from water monitoring conducted on the Fjord or Saguenay rivers for the 2007-2022 period.Organization: Health Canada
February 2024
Req # A-2023-001382
Obtain certain information regarding the state of company records held by your organization. Company: Groupe BFL Inc. (NEQ: 1169110567) 2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Technologies Échangeurs Gaz-Air (TEGA) Inc. (NEQ: 1148440044) 2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Innovation Nagas Inc. (also: Nagas Innovation Inc.) (NEQ: 1166256652) 101-2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Bousquet Technologies Inc. (NEQ: 1142014423) 101-2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9. Company: Bousquet Frères Ltd. (NEQ: 1163420616) 101-2121 Nobel Street, Sainte-Julie, Quebec, J3E 1Z9.Organization: Health Canada
February 2024
Req # A-2023-001385
All communications to/from Health Canada (HC), Public Health Agency Of Canada (PHAC) and National Advisory Committee on Immunization (NACI) or any subcommittee, agency, ad hoc group, project team regarding correspondence from Dr. Theresa (“Tess”) Lawrie or Tess Lawrie about ivermectin in the period of 2020-2023.Organization: Health Canada
February 2024
Req # A-2023-00086
Domino Lane Developments Inc. (the “Purchaser”) purchase from [Names Withheld] (collectively, the “Vendor”) of the lands and premises legally described as PT LT 28 CON 5 OPS AS IN R353263; S/T R353263; KAWARTHA LAKES (being all of PIN 63203-0157 (LT)) and municipally known as 93 Maple Lane Drive, Kawartha Lakes (Lindsay), Ontario K9V 4R1 (the “Property”) Our File No.: 3900-812Organization: Canadian Nuclear Safety Commission
January 2024
Req # A-2023-00087
Orcanfield Developments Inc. (the “Purchaser”) Purchase from Kevin Barker Auctions Ltd. (the “Vendor”) E1/2 LT 28 CON 4 OPS; PT W1/2 LT 28, 27 CON 4 OPS AS IN R458518; S/T O11644; KAWARTHA LAKES; being all of PIN 63203-0056 (LT) 3470 Highway 35 N, City of Kawartha Lakes (Lindsay), Ontario, K9V 4R1(the “Property”) Closing Date: As soon as possible Our File No.: 3900-820Organization: Canadian Nuclear Safety Commission
January 2024
Req # A-2023-000594
All notes made by the Health Canada employees who reviewed the AstraZeneca Vaxzevria COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2020 to July 31, 2020.Organization: Health Canada
January 2024
Req # A-2023-000601
All notes made by the Health Canada employees who reviewed the Janssen Jcovden (Johnson & Johnson) COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2020 to July 31, 2020.Organization: Health Canada
January 2024
Req # A-2023-001171
Information about whether or not Canada donates or sends blood to foreign countries and if yes to which countries did Canada send blood during the years from 2019 until present time.Organization: Health Canada
January 2024
Req # A-2023-001214
Correspondence relating to any abbreviated new drug submission (ANDS) filed since July 1, 2023 where the medicinal ingredient is liraglutide alone and the indication includes chronic weight management.Organization: Health Canada
January 2024
Req # A-2023-001223
Complete copy of documents in your possession relating to the subject company. NEQ : 1167802090.Organization: Health Canada
January 2024